Teladoc Health, Inc.

TDOC

Teladoc Health, Inc. is a leading provider of virtual healthcare services, offering telemedicine solutions that enable patients to consult with healthcare professionals remotely. Founded in 2002, the company provides a range of digital health services, including general medical, mental health, and dermatology consultations, aiming to improve access to quality healthcare through technology.

$6.35 +0.01 (0.16%)
🚫 Teladoc Health, Inc. does not pay dividends

Company News

2 Beaten-Down Stocks That Could Sink Even More in 2026
The Motley Fool • Prosper Junior Bakiny • January 22, 2026

Sarepta Therapeutics and Teladoc Health are identified as two stocks likely to continue declining in 2026. Sarepta faces significant headwinds from safety concerns with its flagship DMD treatment Elevidys, which caused patient deaths and led to restricted access. Teladoc Health struggles with slowing revenue growth, mounting losses, and increased...

Teladoc Health Launches Enhanced 24/7 Care Service
GlobeNewswire Inc. • Lou Serio • January 12, 2026

Teladoc Health announced enhancements to its 24/7 Care virtual urgent care service, expanding treatment capabilities to include a broader range of conditions, enabling specialist consultations during visits, improving preventive care detection, and allowing real-time prescription benefit checks. The service now reaches over 100 million Americans ...

Dialectical Behavior Therapy Market Set to Surge at 9.67% CAGR by 2034, Rising Adoption and Technological Advancements
GlobeNewswire Inc. • Towards Healthcare • November 12, 2025

The global dialectical behavior therapy market is projected to grow from USD 1.31 billion in 2025 to USD 3.29 billion by 2034, driven by rising mental health awareness, technological advancements, and expanding digital therapy platforms.

Is This Beaten-Down Stock Finally on the Road to Recovery?
The Motley Fool • Prosper Junior Bakiny • November 4, 2025

Teladoc Health continues to struggle with declining revenue and profitability challenges, despite potential growth opportunities in mental health services and international expansion. The stock remains unattractive to investors due to competitive landscape and uncertain growth prospects.

Better Beaten-Down Stock: Iovance Biotherapeutics vs. Teladoc Health
The Motley Fool • Prosper Junior Bakiny • October 17, 2025

The article compares two healthcare companies, Iovance Biotherapeutics and Teladoc Health, as potential contrarian investment opportunities. While both companies face challenges, the analysis suggests Teladoc is currently the more attractive option due to its established ecosystem and lower risk profile.

Related Companies